School of Medicine
Showing 1-18 of 18 Results
-
Feng Pan
Postdoctoral Research Fellow, Pathology
Current Research and Scholarly Interests I intend to contribute to a better understanding of the genetic basis of cancer, with a specific focus on the role of epigenetic regulators or epigenetic marks in the pathogenesis of AML. I will also undertake basic work in defining the landscape of mammalian epigenome in both normal and malignant states, and the molecular mechanisms by which integration of all these data establish a 3D regulatory network. I am especially interested in identifying and characterizing the biological mechanisms of cancer stem cells from an epigenetic perspective through which the mechanistic and biological relevance of many epigenetic regulators will be unraveled and connected.
-
Tho Duc Pham
Clinical Assistant Professor, Pathology
Current Research and Scholarly Interests My areas of interest involve exploring antibody function as it relates to transfusion medicine, blood safety, and emerging infectious diseases. This ranges from natural immune responses to the ABO blood group, antibody profiling anti-SARS-CoV-2 antibodies, and studying HEV seroprevalence in the local community. I am also interested in exploring statistical approaches to improve blood product availability and overall health care efficiency in a tertiary care system.
-
Benjamin Pinsky
Associate Professor of Pathology and of Medicine (Infectious Diseases) and, by courtesy, of Pediatrics (Infectious Diseases) at the Stanford University Medical Center
Current Research and Scholarly Interests Development and application of molecular assays for the diagnosis and management of infectious diseases.
-
Jonathan Pollack
Professor of Pathology
Current Research and Scholarly Interests Research in the Pollack lab centers on translational genomics, with a focus on human cancer. The lab employs next-generation sequencing, single-cell genomics, genome editing, and cell/tissue-based modeling to uncover disease mechanisms, biomarkers and therapeutic targets. Current areas of emphasis include diseases of the prostate (prostate cancer and benign prostatic hyperplasia), as well as odontogenic neoplasms.
